The American vaccine pricing market has many actors, making it a complex system to model. Because of this, previous papers have chosen to model only vaccine manufacturers while leaving out the government. However, the government is also an important actor in the market, since it buys over half of vaccines produced. In this work, we aim to introduce the government into vaccine pricing models to better recommend pricing strategies to the Centers for Disease Control and Prevention.
| Identifer | oai:union.ndltd.org:CLAREMONT/oai:scholarship.claremont.edu:hmc_theses-1113 |
| Date | 01 January 2017 |
| Creators | Sinclair, Dina |
| Publisher | Scholarship @ Claremont |
| Source Sets | Claremont Colleges |
| Detected Language | English |
| Type | text |
| Format | application/pdf |
| Source | HMC Senior Theses |
| Rights | Dina Sinclair, default |
Page generated in 0.0014 seconds